Publications

2011

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery
Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, et al. Science, 2011 Dec 01
Humoral immune responses to Plasmodium vivax subtelomeric transmembrane proteins in Thailand
Sungkapong T, Culleton R, Yahata K, Tachibana M, Ruengveerayuth R, Udomsangpetch R, et al. Southeast Asian J Trop Med Public Health, 2011 Nov 01
Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting
Sirichaisinthop J, Buates S, Watanabe R, Han ET, Suktawonjaroenpon W, Krasaesub S, Takeo S, Tsuboi T, Sattabongkot J. Am J Trop Med Hyg, 2011 Oct 01
Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development
Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Ikehara A, Tachibana M, Torii M, Matsuzaki G, Arakawa T. Infect Immun., 2011 Oct 01
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 April 2011-31 May 2011
Bonizzoni M, Bourjea J, Chen B, Crain BJ, Cui L, Fiorentino V, et al. Mol Ecol Resour., 2011 Sep 08
Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion
Lumsden JM, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, et al. Infect Immun., 2011 Sep 01
In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China
Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, et al. Am J Trop Med Hyg., 2011 Aug 17
Determination of the Plasmodium vivax schizont stage proteome
Roobsoong W, Roytrakul S, Sattabongkot J, Li J, Udomsangpetch R, Cui L. J Proteomics., 2011 Aug 02
N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity
Tachibana M, Wu Y, Iriko H, Muratova O, MacDonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T. Clin Vaccine Immunol., 2011 Aug 01
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax
Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, et al. Vaccine, 2011 Jun 08
Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine
Miyata T, Harakuni T, Sugawa H, Sattabongkot J, Kato A, Tachibana M, Torii M, Tsuboi T, Arakawa T. Vaccine, 2011 Mar 20
Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries
Lu F, Lim CS, Nam DH, Kim K, Lin K, Kim TS, et al. Acta Trop., 2011 Feb 02
Genetic polymorphism of Plasmodium vivax msp1p, a paralog of merozoite surface protein 1, from worldwide isolates
Wang Y, Kaneko O, Sattabongkot J, Chen JH, Lu F, Chai JY, et al. Am J Trop Med Hyg., 2011 Feb 01
Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody test
Lee WJ, Kim HH, Hwang SM, Park MY, Kim NR, Cho SH, et al. Malar J., 2011 Jan 19
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, et al. Malar J., 2011 Jan 12
« 2012
2010 »